Europe's STOXX 600 gains as earnings flourish; focus on Fed decision
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
EZ economy grew 0.3% in Q2 qtr on qtr -preliminary estimate
Italy's Intesa Sanpaolo up after raising profit outlook
UK's St James Place soars on cost-cutting plans
STOXX 600 up 0.5%
Updated at 1600 GMT
By Shashwat Chauhan and Pranav Kashyap
July 30 (Reuters) -European shares closed higher on Tuesday, boosted by earnings-driven gains across several pockets of the market, with focus squarely on the Federal Reserve's upcoming rate verdict and the subsequent outlook for monetary policy.
The pan-European STOXX 600 index .STOXX finished 0.5% higher, with the euro zone bank index .SX7E up 1.2%, one of the top gainers among the major STOXX sectors.
Intesa Sanpaolo ISP.MI jumped 3.5% after Italy's biggest bank raised its profit outlook, posting stronger than expected quarterly earnings and signalling additional investor rewards ahead.
Raiffeisen Bank International RBIV.VI added 3.7% after the Austrian lender beat estimates on second quarter profit.
Construction and materials .SXOP gained 1.3% with Spanish builderACS ACS.MC up more than 4% after reporting a 8% rise in first-half net profit.
On the data front, the euro zone economy grew slightly more than expected in the three months to June, but a mixed underlying picture and a string of pessimistic surveys cloud the outlook for the rest of the year.
"With yet another small upside surprise to the GDP data, there is also a case to aim off the surveys a bit," Simon Wells, chief European economist at HSBC, wrote in a note.
"With growth broadly at trend and inflation heading only slowly to target, there is little evidence to suggest that monetary policy is highly restrictive."
Data showed the German economy unexpectedly contracted in the second quarter after skirting a recession at the beginning of the year, with a rise in inflation in July, underlining the continuing struggles of the euro zone's biggest economy.
Investor focus this week will remain on the Federal Reserve, which concludes its two-day rate-setting meeting on Wednesday, with investors anticipating a signal that it could start cutting interest rates in September.
The Bank of England (BoE) will also announce its latest verdict on monetary policy later this week.
Among other headlining stocks, Novo Nordisk NOVOb.CO gained 1.4% after the Danish obesity drugmaker posted a study showing Ozempic reduced tobacco-related health complications among smoking patients with type 2 diabetes.
Britain's St James's Place SJP.L surged 24.8% to the top of the STOXX 600 after the wealth manager outlined a six-year plan to slash costs and revamp its services.
Poste Italiane PST.MI advanced 4.3% as the state-owned postal service group slightly raised its full-year profit goal after operating profit fell less than anticipated in the second quarter.
On the flipside, Britain's Diageo DGE.L slid 5.1% as the world's top spirits maker warned that challenges could persist into next year after it missed full-year profit expectations.
Reporting by Pranav Kashyap and Shashwat Chauhan in Bengaluru; editing by Sonia Cheema and Mark Heinrich
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
